Machine identities now outnumber human users across most enterprises, yet many remain unmanaged, overprivileged, and ...

OpenAI inference cost reduction cut ChatGPT guest traffic from tens of thousands of Nvidia GPUs to just a couple hundred, ...

At least 15 malicious plugins found on the JetBrains Marketplace were designed to steal AI API keys from developers. The campaign, discovered by Aikido Security, includes plugins that act as AI coding ...

Google API keys aren't completely inactive after users delete them, giving attackers a small but significant window to continue abusing them. Joe Leon, researcher at Belgian startup Aikido Security, ...

Web infrastructure provider Vercel disclosed a security breach that may have exposed customer API keys, prompting crypto projects to rotate credentials and review their code. Vercel traced the ...

Dozens of such keys can be extracted from apps’ decompiled code to gain access to all Gemini endpoints. Threat actors can extract Google API keys embedded in Android applications to gain access to ...

A large-scale cybersecurity study has revealed a serious global web security issue involving exposed API credentials tied to major platforms, including Amazon Web Services, Stripe, and OpenAI. After ...

After analyzing 10 million webpages, researchers have found thousands of websites accidentally exposing sensitive API credentials, including keys linked to major services like Amazon Web Services, ...

AI Economy: A team of three developers in Mexico is facing a roughly 455× increase in monthly AI service expenses after an API key associated with their project was allegedly compromised. The key was ...

New research has found that Google Cloud API keys, typically designated as project identifiers for billing purposes, could be abused to authenticate to sensitive Gemini endpoints and access private ...

Google Cloud API keys, normally used as simple billing identifiers for APIs such as Maps or YouTube, could be scraped from websites to give access to private Gemini AI project data, researchers from ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...